InvestorsHub Logo

nidan7500

11/08/20 9:34 AM

#281785 RE: Jonjones325 #281782

JonJ-Nailed it.

boi568

11/08/20 9:38 AM

#281788 RE: Jonjones325 #281782

"We de-risked enormously on Friday."

I agree, and not just by dropping under $5.

JWC3

11/08/20 9:44 AM

#281795 RE: Jonjones325 #281782

We got 15 minutes of information. Expecting perfection of completeness and complaining about not getting it is just childish. The ANAVEX slide package given is more than should have been expected. The results revealed are so uniformly supportive of the p2a AD trial results it is difficult to imagine that it could have been any better. I believe your conclusions are a good assessment. Thank you.

plexrec

11/08/20 10:42 AM

#281810 RE: Jonjones325 #281782

Jon--" this was a huge homerun."--great post and agree !!!! GLTU !!

Turner2017

11/08/20 10:46 AM

#281813 RE: Jonjones325 #281782

GREAT post!!!! Cant wait for Rett results!!

pcguy

11/08/20 10:53 AM

#281818 RE: Jonjones325 #281782

This is exactly what you want from a CEO...:

Missling and gang knew already and that was most likely the chant in the office while holding hands and jumping around like a bunch of school girls.



Glad to finally understand this investment.

Investor2014

11/08/20 11:37 AM

#281827 RE: Jonjones325 #281782

Yep not at all bad.

There is nothing revenue driving on the immediate horizon.

The SP going down was just good old fashioned sell the news. No cabal needed.

Great and predictable way to take profit and join again for the next round, but hopefully that opportunity will eventually fade with P3 trial readouts.

mrplmer

11/08/20 11:41 AM

#281828 RE: Jonjones325 #281782

Friday wasn't just profit-taking. It was shorting again. We need a deal!

tredenwater2

11/08/20 12:58 PM

#281839 RE: Jonjones325 #281782

But in my eyes and most likely Misslings eyes, this was a huge homerun.



JJ good point. Makes me wonder how Eli Lilly’s results faired? Will they get a LB spot at next years prestigous CTAD conference......uhm NO because their Alzheimer’s drug crashed and burned while ours SUPPORTED our Alzheimer’s trial MOA. Most likely we will see them at one of the upcoming Parkinsons conferences.

Perhaps this Parkinsons release at an Alzheimer’s conference served more than one unforseen purpose. It allowed us to expose our limited great results in a different light highlighting/reinforcing our Alzheimer’s trial and the best (full analysis 3rd party peer reviewed) is yet to come. A really high end hors d’oeuvre if you will or “bonus”! Im sure Lilly is well aware of our findings and may now just be picking their jaw up off the ground!

We will see!

Tred